BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 26506596)

  • 1. A novel gammaretroviral shuttle vector insertional mutagenesis screen identifies SHARPIN as a breast cancer metastasis gene and prognostic biomarker.
    Bii VM; Rae DT; Trobridge GD
    Oncotarget; 2015 Nov; 6(37):39507-20. PubMed ID: 26506596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel approach to identify driver genes involved in androgen-independent prostate cancer.
    Schinke EN; Bii V; Nalla A; Rae DT; Tedrick L; Meadows GG; Trobridge GD
    Mol Cancer; 2014 May; 13():120. PubMed ID: 24885513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replication-incompetent gammaretroviral and lentiviral vector-based insertional mutagenesis screens identify prostate cancer progression genes.
    Bii VM; Collins CP; Hocum JD; Trobridge GD
    Oncotarget; 2018 Mar; 9(21):15451-15463. PubMed ID: 29643985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying Cancer Driver Genes Using Replication-Incompetent Retroviral Vectors.
    Bii VM; Trobridge GD
    Cancers (Basel); 2016 Oct; 8(11):. PubMed ID: 27792127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide screen identifies a novel prognostic signature for breast cancer survival.
    Mao XY; Lee MJ; Zhu J; Zhu C; Law SM; Snijders AM
    Oncotarget; 2017 Feb; 8(8):14003-14016. PubMed ID: 28122328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells.
    Bartucci M; Dattilo R; Moriconi C; Pagliuca A; Mottolese M; Federici G; Benedetto AD; Todaro M; Stassi G; Sperati F; Amabile MI; Pilozzi E; Patrizii M; Biffoni M; Maugeri-Saccà M; Piccolo S; De Maria R
    Oncogene; 2015 Feb; 34(6):681-90. PubMed ID: 24531710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel retroviral mutagenesis screen identifies prognostic genes in RUNX1 mediated myeloid leukemogenesis.
    Rae DT; Hocum JD; Bii V; Deeg HJ; Trobridge GD
    Oncotarget; 2015 Oct; 6(31):30664-74. PubMed ID: 26384344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of HERV-K Env protein is essential for tumorigenesis and metastasis of breast cancer cells.
    Zhou F; Li M; Wei Y; Lin K; Lu Y; Shen J; Johanning GL; Wang-Johanning F
    Oncotarget; 2016 Dec; 7(51):84093-84117. PubMed ID: 27557521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BHLHE40 confers a pro-survival and pro-metastatic phenotype to breast cancer cells by modulating HBEGF secretion.
    Sethuraman A; Brown M; Krutilina R; Wu ZH; Seagroves TN; Pfeffer LM; Fan M
    Breast Cancer Res; 2018 Oct; 20(1):117. PubMed ID: 30285805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transposon insertional mutagenesis in mice identifies human breast cancer susceptibility genes and signatures for stratification.
    Chen L; Jenjaroenpun P; Pillai AM; Ivshina AV; Ow GS; Efthimios M; Zhiqun T; Tan TZ; Lee SC; Rogers K; Ward JM; Mori S; Adams DJ; Jenkins NA; Copeland NG; Ban KH; Kuznetsov VA; Thiery JP
    Proc Natl Acad Sci U S A; 2017 Mar; 114(11):E2215-E2224. PubMed ID: 28251929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SHARPIN Promotes Melanoma Progression via Rap1 Signaling Pathway.
    Zhou S; Liang Y; Zhang X; Liao L; Yang Y; Ouyang W; Xu H
    J Invest Dermatol; 2020 Feb; 140(2):395-403.e6. PubMed ID: 31401046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic functional perturbations uncover a prognostic genetic network driving human breast cancer.
    Gallenne T; Ross KN; Visser NL; Salony ; Desmet CJ; Wittner BS; Wessels LFA; Ramaswamy S; Peeper DS
    Oncotarget; 2017 Mar; 8(13):20572-20587. PubMed ID: 28411283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating miRNAs with prognostic value in metastatic breast cancer and for early detection of metastasis.
    Madhavan D; Peng C; Wallwiener M; Zucknick M; Nees J; Schott S; Rudolph A; Riethdorf S; Trumpp A; Pantel K; Sohn C; Chang-Claude J; Schneeweiss A; Burwinkel B
    Carcinogenesis; 2016 May; 37(5):461-70. PubMed ID: 26785733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional genomics identifies AMPD2 as a new prognostic marker for undifferentiated pleomorphic sarcoma.
    Orth MF; Gerke JS; Knösel T; Altendorf-Hofmann A; Musa J; Alba-Rubio R; Stein S; Hölting TLB; Cidre-Aranaz F; Romero-Pérez L; Dallmayer M; Baldauf MC; Marchetto A; Sannino G; Knott MML; Wehweck F; Ohmura S; Li J; Hakozaki M; Kirchner T; Dandekar T; Butt E; Grünewald TGP
    Int J Cancer; 2019 Feb; 144(4):859-867. PubMed ID: 30267407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insertional gene activation by lentiviral and gammaretroviral vectors.
    Bokhoven M; Stephen SL; Knight S; Gevers EF; Robinson IC; Takeuchi Y; Collins MK
    J Virol; 2009 Jan; 83(1):283-94. PubMed ID: 18945765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing PRDM14 expression by an innovative RNAi therapy inhibits stemness, tumorigenicity, and metastasis of breast cancer.
    Taniguchi H; Hoshino D; Moriya C; Zembutsu H; Nishiyama N; Yamamoto H; Kataoka K; Imai K
    Oncotarget; 2017 Jul; 8(29):46856-46874. PubMed ID: 28423353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sense-antisense gene-pairs in breast cancer and associated pathological pathways.
    Grinchuk OV; Motakis E; Yenamandra SP; Ow GS; Jenjaroenpun P; Tang Z; Yarmishyn AA; Ivshina AV; Kuznetsov VA
    Oncotarget; 2015 Dec; 6(39):42197-221. PubMed ID: 26517092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation of metastasis-free survival in patients with breast cancer and changes in the direction of expression of multidrug resistance genes during neoadjuvant chemotherapy].
    Litviakov NV; Garbukov EIu; Slonimskaia EM; Tsyganov MM; Denisov EV; Vtorushin SV; Khristenko KIu; Zav'ialova MV; Cherdyntseva NV
    Vopr Onkol; 2013; 59(3):334-40. PubMed ID: 23909034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of breast cancer candidate genes using gene co-expression and protein-protein interaction information.
    Yue Z; Li HT; Yang Y; Hussain S; Zheng CH; Xia J; Chen Y
    Oncotarget; 2016 Jun; 7(24):36092-36100. PubMed ID: 27150055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-200b expression in breast cancer: a prognostic marker and act on cell proliferation and apoptosis by targeting Sp1.
    Yao Y; Hu J; Shen Z; Yao R; Liu S; Li Y; Cong H; Wang X; Qiu W; Yue L
    J Cell Mol Med; 2015 Apr; 19(4):760-9. PubMed ID: 25639535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.